XML 50 R21.htm IDEA: XBRL DOCUMENT
v3.24.1

Other Non-Financial Assets | 12 Months Ended
--- | ---
Dec. 31, 2023
Other Non-Financial Assets [Abstract] |
Other Non-Financial Assets | Other Non-Financial Assets
(in millions €) |  | December 31, 2023 | December 31, 2022
Deferred expenses |  | 313.2 | 120.0
Sales tax receivable |  | 5.2 | 93.8
Prepayments related to CRO and CMO contracts |  | — | 35.3
Other |  | 45.9 | 29.3
Total |  | 364.3 | 278.4
Total current |  | 280.9 | 271.9
Total non-current |  | 83.4 | 6.5
Deferred expenses mainly comprise prepayments for future expenses of €151.1 million (nil as of December 31, 2022) for the settlement fee of the European Commission to our collaboration partner and prepayments for our collaborations with OncoC4 Inc., Rockville, USA, €22.5 million (nil as of December 31, 2022), Ryvu Therapeutics S.A., Krakau, Poland, €15.7 million (€19.7 million as of December 31, 2022) and Medigene Immunotherapies GmbH, Planegg/Martinsried, €5.1 million (€9.4 million as of December 31, 2022). Prior year deferred expenses mainly comprise service contracts and insurance obligations.

X
- Definition Other Non-Financial Assets + References No definition available. + Details
Name: | bntx_OtherNonFinancialAssetsAbstract
Namespace Prefix: | bntx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of other assets. [Refer: Other assets] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfOtherAssetsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration